Zobrazeno 1 - 10 of 54 pro vyhledávání: '"P H Vlasses"'
1
The effect of amiodarone on theophylline pharmacokinetics in the rat
Autor: G E, Larijani, M L, Rocci, P, Mojaverian, C L, Saccar, C, Hoholick, P H, Vlasses
Publikováno v: Pharmaceutical research. 3(3)
Amiodarone is an investigational antiarrhythmic agent which has been implicated in reducing the activity of the hepatic mixed-function oxidase system. To evaluate this effect further, two groups of six male Sprague-Dawley rats each received theophyll
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::84990ab9577c1f466ae81291b9bd5777
https://pubmed.ncbi.nlm.nih.gov/24271523
Zobrazit plný text záznamu
3
Using a multihospital systems framework to evaluate and establish drug use policy
Autor: L C, Vermeulen, P A, Windisch, R J, Rydman, R H, Bruskiewitz, D I, Brixner, P H, Vlasses
Publikováno v: Journal of medical systems. 24(4)
In order to develop rational drug purchasing and use policy for a class of pharmaceuticals used in a consortium system of 14 university based hospitals, the antiemetic use patterns of inpatients receiving cancer chemotherapy were evaluated to assess
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::fb643ec04a981d21725db59e87aa0dd2
https://pubmed.ncbi.nlm.nih.gov/11057402
Zobrazit plný text záznamu
4
Cost-offset analysis of aprotinin in high-risk coronary artery bypass
Autor: P D, Meek, P H, Vlasses, M E, Sura, R E, Walsh, L C, Vermeulen
Publikováno v: Pharmacy practice management quarterly. 19(2)
Aprotinin, a naturally occurring protease inhibitor derived from bovine lung, is used prophylactically to minimize the amount of perioperative blood loss in patients undergoing coronary artery bypass graft surgery who are at high risk for excessive b
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5529071d0cb6aacdcc2da20f8b3d039b
https://pubmed.ncbi.nlm.nih.gov/10558092
Zobrazit plný text záznamu
6
Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals
Autor: G W, Albers, J M, Yim, K M, Belew, N, Bittar, C R, Hattemer, B G, Phillips, S, Kemp, E A, Hall, D J, Morton, P H, Vlasses
Publikováno v: Archives of internal medicine. 156(20)
The risk of stroke in patients with atrial fibrillation can be significantly reduced with antithrombotic therapy. Despite this, many physicians remain hesitant to prescribe warfarin sodium or aspirin therapy for patients with atrial fibrillation.To a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a33453b36ca8859ddccb16ff3c5d5460
https://pubmed.ncbi.nlm.nih.gov/9224231
Zobrazit plný text záznamu
7
Albumin and nonprotein colloid solution use in US academic health centers
Autor: J M, Yim, L C, Vermeulen, B L, Erstad, K A, Matuszewski, D A, Burnett, P H, Vlasses
Publikováno v: Archives of internal medicine. 155(22)
Crystalloids, nonprotein colloids (NPCs), and albumin are used for many indications. The use of the least costly agent in situations where these products are clinically interchangeable can reduce health care costs.To characterize the prescribing of a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::42129dfd6b14c40c38c7057dcb1453e0
https://pubmed.ncbi.nlm.nih.gov/7503604
Zobrazit plný text záznamu
8
Evaluation of ondansetron prescribing in US academic medical centers
Autor: L C, Vermeulen, K A, Matuszewski, T A, Ratko, C D, Butler, D A, Burnett, P H, Vlasses
Publikováno v: Archives of internal medicine. 154(15)
The study objectives were to characterize the use of the antiemetic ondansetron, a serotonin subtype 3 receptor antagonist, in US academic medical centers, and to assess ondansetron prescribing with consensus-derived prescribing guidelines used as ev
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5395d98bedf6b829ffab7a2c7cbd768e
https://pubmed.ncbi.nlm.nih.gov/8042890
Zobrazit plný text záznamu
9
Pharmacotherapy specialty certification examination. IV. 1992 results and process modifications, including recertification. The 1992 Specialty Council on Pharmacotherapy, Board of Pharmaceutical Specialties
Autor: B J, Zarowitz, P H, Vlasses, G E, Dukes, P, Gal, W A, Miller, W C, Porter, D R, Rush, P, Schneider, R L, Talbert
Publikováno v: Pharmacotherapy. 13(3)
Certification of pharmacotherapy specialists is proceeding smoothly. Modifications to the examination process, which include reapportioning domains, offering the examination at several sites, and establishing the recertification process, have occurre
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ea005096671abd70c6c073a919c20011
https://pubmed.ncbi.nlm.nih.gov/8321740
Zobrazit plný text záznamu
10
Clinical pharmacology and economics of recombinant human erythropoietin in end-stage renal disease: the case for subcutaneous administration
Autor: P H Vlasses, F Medina, E Morris, J B McCrea, K K Flaharty, J Caro, A J Erslev, Anatole Besarab
Publikováno v: Journal of the American Society of Nephrology : JASN. 2(9)
The clinical pharmacology of human recombinant erythropoietin (epoetin) was studied in order to compare the effectiveness of various routes and dosing schedules in dialysis patients. Thirty-six patients received epoetin beta three times a week i.v. f
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a7335c98f23ec889c1c1b7266f99444
https://pubmed.ncbi.nlm.nih.gov/1627763
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje